Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aronex Pharma (ARNX) -- Ignore unavailable to you. Want to Upgrade?

To: Sam Lee who wrote (136)	8/29/1998 11:15:00 AM
From: Sam Lee	Read Replies (1) \| Respond to of 320

NDA Rumors Atrogen NDA to be filed in December and Nyotran to be filed in 1st qtr 1999. Some rising hope that Atrogen will have wide spread use. No word on current status of negotiations.In the meantime,yes,we are running out of money. This is not a stock for the feint hearted.Remember Bobby Thomson's dramatic 9th inning home run in the 1951 playoff against the Dodgers? That is what we need. Once in a while it happens. IMHO. I have no more thoughts.